Gut microbiota and immune modulation: role in neurodegenerative disorders and cancer
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-12155-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 17.06.2026. Verfasst von Kumari Anchu Dogra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Bioengineering and Biosciences, Lovely Professional University, Punjab, 144411, Phagwara, India. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Neoplasms, Gastrointestinal Microbiome, Immunomodulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 108 Literaturangaben.
Abstract (Originalsprache)
The gut microbiota plays a crucial role in maintaining host metabolic balance and immune homeostasis, with increasing evidence linking its dysregulation to neurodegenerative diseases and cancer. This review aims to provide a comprehensive and integrative analysis of gut microbiota-mediated immune modulation in Parkinson's disease, Alzheimer's disease, and cancer. A structured literature-based approach was employed to examine recent studies focusing on microbial composition, metabolite production, and host microbe immune interactions. We summarize the role of key microbial metabolites, particularly short-chain fatty acids, in regulating immune responses, maintaining gut barrier integrity, and modulating systemic inflammation. In addition, the bidirectional communication along the gut-brain axis is discussed, highlighting its differential involvement in neurodegenerative disorders, while microbiota driven immune mechanisms contributing to tumorigenesis are also evaluated. Importantly, this review emphasizes the translational relevance of microbiome-targeted interventions, including prebiotics, probiotics, synbiotics, and emerging postbiotic strategies, in modulating disease progression and therapeutic outcomes. Although limitations lies in correlating the human gut microbiota to the results obtained from the animal studies which may not fully reflect the physiological conditions of the human gut as it is affected by several factors, this work provides a unified framework linking gut microbiota, immune regulation, and disease pathogenesis, and outlines future directions for the development of targeted and personalized microbiome-based therapies which may be achieved through well designed longitudinal and large scale clinical studies further.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, School of Bioengineering and Biosciences, Lovely Professional University, Punjab, 144411, Phagwara, India.
- Department of Zoology, Maulana Azad College, Kolkata, West Bengal, India. nabanitaghosh89@gmail.com.
- Department of Plant Pathology, School of Agriculture, Lovely Professional University, Punjab, 144411, Phagwara, India.
- Department of Emergency Medicine, University of Nebraska Medical Centre, Omaha, NE, USA.
- Department of Biochemistry, School of Bioengineering and Biosciences, Lovely Professional University, Punjab, 144411, Phagwara, India. priyobiochem@gmail.com.
Zitieren
APA
Dogra, K. A., Sharma, M., Ghosh, N., Kaur, G., Singh, J., & Sinha, P. (2026). Gut microbiota and immune modulation: role in neurodegenerative disorders and cancer. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12155-5
Vancouver
Dogra KA, Sharma M, Ghosh N, Kaur G, Singh J, Sinha P. Gut microbiota and immune modulation: role in neurodegenerative disorders and cancer. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12155-5
BibTeX
@article{Dogra2026,
author = {Dogra, Kumari Anchu and Sharma, Mamta and Ghosh, Nabanita and Kaur, Gurpreet and Singh, Jaswinder and Sinha, Priyobrata},
title = {Gut microbiota and immune modulation: role in neurodegenerative disorders and cancer},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-12155-5}
}
EUVIMED